AZA-CR
Showing 1 - 25 of 1,560
Chronic Myelomonocytic Leukemia Trial in Houston (Azacitidine, Tamibarotene, Venetoclax)
Not yet recruiting
- Chronic Myelomonocytic Leukemia
- Azacitidine
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 10, 2023
Acute Myeloid Leukemia Trial in Houston (Azacitidine, Venetoclax, NK Cells)
Not yet recruiting
- Acute Myeloid Leukemia
- Azacitidine
- +2 more
-
Houston, TexasM.D. Anderson Cancer Center
Apr 17, 2023
Hodgkin's Lymphoma Trial in Houston (Azacytidine, Pembrolizumab)
Recruiting
- Hodgkin's Lymphoma
-
Houston, TexasMD Anderson Cancer Center
Oct 5, 2022
Leukemia Trial in Houston (Brentuximab Vedotin, 5-Azacytidine)
Terminated
- Leukemia
- Brentuximab Vedotin
- 5-Azacytidine
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 7, 2022
MDS, Myeloproliferative Chronic Myelomonocytic Leukemia Trial in Houston (Cladribine, Cytarabine, Venetoclax)
Recruiting
- Myelodysplastic Syndromes
- Myeloproliferative Chronic Myelomonocytic Leukemia
- Cladribine
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 31, 2022
Leukemia Trial in Houston (Decitabine, Azacitidine)
Completed
- Leukemia
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 1, 2020
Leukemia Trial in United States (Azacitidine (AZA) Days 1 - 3, Decitabine (DAC), Best Supportive Care (BSC))
Active, not recruiting
- Leukemia
- Azacitidine (AZA) Days 1 - 3
- +3 more
-
Tampa, Florida
- +5 more
Jul 21, 2020
Colorectal Cancer Trial in Houston (Azacitidine, Capecitabine, Oxaliplatin)
Completed
- Colorectal Cancer
- Azacitidine
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Apr 3, 2020
Leukemia Trial in Houston (Azacitidine (AZA), Tyrosine kinase inhibitor (TKI), Azacitidine)
Completed
- Leukemia
- Azacitidine (AZA)
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 3, 2020
Advanced Cancers, Lymphoma Trial in Houston (Azacitidine, Vorinostat, Gemcitabine)
Completed
- Advanced Cancers
- Lymphoma
- Azacitidine
- +9 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 14, 2020
Leukemia Trial in Houston (Lirilumab, Nivolumab, Azacitidine)
Terminated
- Leukemia
- Lirilumab
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 6, 2020
Leukemia, AML, MDS Trial in Houston (Azacitidine)
Completed
- Leukemia
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 6, 2020
Acute Myeloid Leukemia Trial in Copenhagen (Venetoclax)
Recruiting
- Acute Myeloid Leukemia
-
Copenhagen, DenmarkDepartment of Hematology, Rigshospitalet
Jun 21, 2022
Leukemia Trial in Houston (Azacytidine, Sorafenib)
Completed
- Leukemia
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 6, 2020
Acute Myeloid Leukemia (AML) Trial in Leipzig (VEN+AZA-5)
Not yet recruiting
- Acute Myeloid Leukemia (AML)
-
Leipzig, GermanyUniversitätsklinikum Leipzig, Klinik und Poliklinik für Hämatolo
Apr 25, 2023
Acute Myeloid Leukemia Trial in Tianjin (Different induction chemo regimens)
Not yet recruiting
- Acute Myeloid Leukemia
- Different induction chemotherapy regimens
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Sep 27, 2023
MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)
Recruiting
- MDS/MPN
- Azacitidine (AZA) with Ruxolitinib
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Apr 17, 2023
Acute Myeloid Leukemia Trial in Suzhou (Azacitidine Combined With Venetoclax and ATRA group)
Recruiting
- Acute Myeloid Leukemia
- Azacitidine Combined With Venetoclax and ATRA group
-
Suzhou, Chinathe First Affiliated Hospital of Soochow University
Dec 8, 2022
Acute Myeloid Leukemia Trial in Italy (Vidaza 100 milligram (mg) injection, Best Supportive Care)
Completed
- Acute Myeloid Leukemia
- Vidaza 100 milligram (mg) injection
- Best Supportive Care
-
Alessandria, AL, Italy
- +17 more
Jan 13, 2022
Myeloid Malignancies Trial in Australia, United Kingdom, United States (Magrolimab, Azacitidine, Venetoclax)
Recruiting
- Myeloid Malignancies
- Magrolimab
- +6 more
-
Birmingham, Alabama
- +12 more
Apr 6, 2022
Acute Myeloid Leukemia Trial in NanJing (Homoharringtonine, Azacitidine)
Recruiting
- Acute Myeloid Leukemia
-
NanJing, ChinaDepartment of Hematology, Zhongda Hospital, Medical School of So
Sep 2, 2022
AML, Adult, Refractory AML, Relapsed Adult AML Trial in France (AzaCITIDine Oral Tablet, Xospata)
Not yet recruiting
- AML, Adult
- +4 more
- AzaCITIDine Oral Tablet
- Xospata
-
Amiens, France
- +19 more
Sep 1, 2023
Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Houston (DSP107, Azacitidine, Venetoclax)
Recruiting
- Acute Myeloid Leukemia
- +2 more
- DSP107
- +2 more
-
Houston, TexasThe University of Texas MD Anderson Cancer Center, Department of
Nov 13, 2022
Acute Myeloid Leukemia Trial in Worldwide (Pracinostat, Placebos, Azacitidine)
Recurrent Ependymoma Trial in Houston (5-Azacytidine (5-AZA) group 1, 5-Azacytidine (5-AZA) group 2, 5-Azacytidine (5-AZA) group
Recruiting
- Recurrent Ependymoma
- 5-Azacytidine (5-AZA) group 1
- +2 more
-
Houston, TexasThe University of Texas Health Science Center at Houston
Aug 17, 2022